CVS Health Corp (CVS) Shares Bought by St. Johns Investment Management Company LLC

St. Johns Investment Management Company LLC raised its position in shares of CVS Health Corp (NYSE:CVS) by 7.9% in the fourth quarter, HoldingsChannel reports. The firm owned 15,706 shares of the pharmacy operator’s stock after acquiring an additional 1,154 shares during the period. St. Johns Investment Management Company LLC’s holdings in CVS Health were worth $1,029,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Bell Rock Capital LLC raised its position in shares of CVS Health by 764.0% in the 4th quarter. Bell Rock Capital LLC now owns 432 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 382 shares in the last quarter. Daiwa SB Investments Ltd. bought a new position in shares of CVS Health in the 4th quarter worth $30,000. Cornerstone Advisors Inc. raised its position in shares of CVS Health by 71.6% in the 3rd quarter. Cornerstone Advisors Inc. now owns 508 shares of the pharmacy operator’s stock worth $40,000 after acquiring an additional 212 shares in the last quarter. Certified Advisory Corp raised its position in shares of CVS Health by 46.3% in the 4th quarter. Certified Advisory Corp now owns 638 shares of the pharmacy operator’s stock worth $42,000 after acquiring an additional 202 shares in the last quarter. Finally, ETF Managers Group LLC bought a new position in shares of CVS Health in the 4th quarter worth $43,000. 90.60% of the stock is owned by institutional investors and hedge funds.

Get CVS Health alerts:

NYSE:CVS traded down $0.87 during mid-day trading on Monday, hitting $57.26. 2,056,350 shares of the company’s stock traded hands, compared to its average volume of 11,071,835. CVS Health Corp has a twelve month low of $57.56 and a twelve month high of $82.15. The firm has a market capitalization of $63.11 billion, a P/E ratio of 8.09, a P/E/G ratio of 0.90 and a beta of 1.03. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.03 and a quick ratio of 1.94.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, February 20th. The pharmacy operator reported $2.14 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.07 by $0.07. The business had revenue of $54.42 billion for the quarter, compared to the consensus estimate of $53.78 billion. CVS Health had a positive return on equity of 17.49% and a negative net margin of 0.31%. The company’s quarterly revenue was up 12.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.92 EPS. On average, analysts expect that CVS Health Corp will post 6.8 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Monday, February 4th. Shareholders of record on Friday, January 25th were paid a dividend of $0.50 per share. The ex-dividend date was Thursday, January 24th. This represents a $2.00 annualized dividend and a yield of 3.49%. CVS Health’s payout ratio is presently 28.25%.

CVS has been the subject of several recent research reports. ValuEngine raised CVS Health from a “sell” rating to a “hold” rating in a research report on Tuesday, November 6th. Royal Bank of Canada set a $100.00 price target on CVS Health and gave the stock a “buy” rating in a research report on Wednesday, November 7th. Morgan Stanley set a $100.00 price target on CVS Health and gave the stock a “buy” rating in a research report on Wednesday, November 7th. Leerink Swann boosted their price target on CVS Health from $85.00 to $95.00 and gave the stock a “positive” rating in a research report on Thursday, November 8th. Finally, Loop Capital set a $80.00 target price on CVS Health and gave the company a “hold” rating in a research report on Friday, November 9th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have issued a buy rating to the company. CVS Health currently has an average rating of “Buy” and a consensus target price of $85.50.

In other CVS Health news, insider Larry J. Merlo sold 166,368 shares of the business’s stock in a transaction dated Tuesday, January 8th. The stock was sold at an average price of $69.04, for a total transaction of $11,486,046.72. Following the sale, the insider now owns 496,577 shares in the company, valued at approximately $34,283,676.08. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Jonathan C. Roberts sold 77,639 shares of the business’s stock in a transaction dated Friday, February 1st. The shares were sold at an average price of $64.54, for a total value of $5,010,821.06. The disclosure for this sale can be found here. In the last quarter, insiders have sold 412,039 shares of company stock worth $27,326,012. Company insiders own 0.53% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “CVS Health Corp (CVS) Shares Bought by St. Johns Investment Management Company LLC” was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://www.tickerreport.com/banking-finance/4196785/cvs-health-corp-cvs-shares-bought-by-st-johns-investment-management-company-llc.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Featured Article: How to interpret a stock's beta number

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).